Morphine sulfate extended-release tablets may lead to significant hypotension like orthostatic hypotension and syncope in ambulatory sufferers. There may be an elevated risk in individuals whose capacity to keep up blood pressure has previously been compromised by a minimized blood volume or concurrent administration of specific CNS depressant medi